| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Corticosteroid therapy in ulcerative colitis: Clinical response and predictors
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jin Li, Fan Wang, Hong-Jie Zhang, Jian-Qiu Sheng, Wen-Feng Yan, Min-Xing Ma, Ru-Ying Fan, Fang Gu, Chuan-Feng Li, Da-Fan Chen, Ping Zheng, Yu-Pei Gu, Qian Cao, Hong Yang, Jia-Ming Qian, Pin-Jin Hu and Bing Xia |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Ministry of Public Health |
201002020 |
| Hubei Provincial Outstanding Medical Academic Leader Program (2013) |
|
|
| Corresponding Author |
Bing Xia, Professor, Department of Gastroenterology, Zhongnan Hospital of Wuhan University, No. 169, Donghu Road, Wuchang District, Wuhan 430071, Hubei Province, China. bingxia@aliyun.com |
| Key Words |
Clinical response; Predictor; Corticosteroid; Ulcerative colitis |
| Core Tip |
This is the first large-scale study across mainland China to evaluate clinical response to initial corticosteroid (CS) treatment in ulcerative colitis (UC) and identify predictors of clinical response, although recent studies have focused on the treatment outcomes of new drugs for UC. CS therapy continues to one of the most effective treatments in active UC. In view of the great difference between yellow and white races in CS response, and the lack of large-scale, systematic CS studies in yellow-race UC patients, this study was meaningful in understanding the efficacy of and risk factors for initial CS treatment in yellow-race UC patients. |
| Publish Date |
2015-03-16 18:04 |
| Citation |
Li J, Wang F, Zhang HJ, Sheng JQ, Yan WF, Ma MX, Fan RY, Gu F, Li CF, Chen DF, Zheng P, Gu YP, Cao Q, Yang H, Qian JM, Hu PJ, Xia B. Corticosteroid therapy in ulcerative colitis: Clinical response and predictors. World J Gastroenterol 2015; 21(10): 3005-3015 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i10/3005.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i10.3005 |
